Most meningiomas express EMA with a decreased expression index in high-risk meningiomas (WHO grade 2 and 3) and vimentin is also present in the majority of cases of meningiomas, especially in high-risk ones (grade 2 and 3) [23]. This evidence concerns the gene MUC1 and meningioma.